Frankfurt Cancer Institute (FCI)

Germany

1 September 2020 - 31 August 2021

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Frankfurt Cancer Institute (FCI) published between 1 September 2020 - 31 August 2021 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: Frankfurt Cancer Institute (FCI) is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

Count Share
10 1.13

Outputs by subject (Share)

Subject Count Share
Life Sciences 9 0.98
Physical Sciences 1 0.13
Chemistry 2 0.17

1 September 2020 - 31 August 2021

International vs. domestic collaboration by Share

  • 83.9% Domestic
  • 16.1% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (27 total)

  • Frankfurt Cancer Institute (FCI), Germany
  • Domestic institution
  1. Goethe University Frankfurt (GU), Germany (3.54)
    1.13
    2.41
  2. Max Planck Society, Germany (3.03)
    1.13
    1.90
  3. Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy, Germany (2.05)
    1.13
    0.92
  4. Helmholtz Association of German Research Centres, Germany (2.01)
    1.13
    0.88
  5. Paul-Ehrlich-Institut (PEI), Germany (1.44)
    1.13
    0.31
  6. University of Göttingen, Germany (0.73)
    0.34
    0.39
  7. Giessen University (JLU), Germany (0.49)
    0.19
    0.30
  8. Cluster of Excellence - The Cardio-Pulmonary Institute (CPI), Germany (0.45)
    0.19
    0.26
  9. The German Center for Lung Research (DZL), Germany (0.42)
    0.16
    0.26
  10. DKTK Partner Site Frankfurt/Mainz, Germany (0.41)
    0.22
    0.19

Top 10 international collaborators by Share (31 total)

  • Frankfurt Cancer Institute (FCI), Germany
  • Foreign institution
  1. University of Cambridge, United Kingdom (UK) (0.42)
    0.02
    0.40
  2. National Institutes of Health (NIH), United States of America (USA) (0.34)
    0.06
    0.28
  3. Catholic University of Leuven (KU Leuven), Belgium (0.29)
    0.19
    0.10
  4. Thermo Fisher Scientific Inc., United States of America (USA) (0.29)
    0.14
    0.14
  5. Northwestern University (NU), United States of America (USA) (0.26)
    0.06
    0.19
  6. F. Hoffmann-La Roche AG, Switzerland (0.24)
    0.19
    0.05
  7. Ono Pharmaceutical Co., Ltd., Japan (0.23)
    0.15
    0.08
  8. Swiss Federal Institute of Technology Zurich (ETH Zurich), Switzerland (0.14)
    0.03
    0.11
  9. enGene Statistics GmbH, Switzerland (0.12)
    0.06
    0.06
  10. Singapore Health Services Pte. Ltd. (SingHealth), Singapore (0.10)
    0.02
    0.08

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Frankfurt Cancer Institute (FCI)

Participating institutions

Frankfurt Cancer Institute (FCI) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Creative Commons License

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Return to institution outputs

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER